The Path to a Molecular Diagnosis: Genetics and Pathology

Because ALPI-related IBD is an ultra-rare condition, the diagnosis cannot be made by looking at symptoms or a colonoscopy alone. It requires a “molecular diagnosis”—a definitive identification of an altered genetic blueprint.

Getting to this diagnosis often involves three layers of evidence: genetic sequencing, stool enzyme activity, and microscopic examination of the intestinal tissue.

The Core Diagnosis: Trio Genetic Sequencing

The most critical step in diagnosing ALPI-related IBD is Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), or a targeted multigene panel ^[1][2].

Doctors strongly prefer what is called trio sequencing ^[3]. This means the child and both biological parents are tested at the same time. This is essential for two reasons:

1. Confirming “Biallelic” Status: To have this disease, a child must have two altered copies of the ALPI gene. Trio testing confirms the child inherited one mutation from the mother and one from the father—a state called being in trans ^[4].
2. Filtering Noise: Every human has thousands of genetic variations. By comparing the child’s DNA to the parents’, scientists can quickly filter out harmless variations and focus only on the mutations that could be causing the disease ^[3].

If a test only finds one ALPI variant, the patient is not necessarily just a “carrier.” Exome sequencing can miss copy-number variants, deep-intronic variants, or large deletions, and a “Variant of Uncertain Significance” (VUS) requires expert review. Finding one variant warrants further review by a clinical geneticist or reanalysis rather than ruling the condition out.

Supportive Testing: Stool and Tissue

While genetics provide the “why,” stool and tissue tests can provide supportive evidence, though they are not diagnostic requirements.

• Stool ALPI Activity: Doctors may test a stool sample for alkaline phosphatase activity. In documented cases of ALPI-related IBD, this activity was undetectable ^[4]. However, it is important to know that stool activity can also be low due to inflammation in “standard” IBD or altered sample handling, so it should be paired with genetic confirmation ^[5][6].
• Tissue Biopsy Staining: During an endoscopy, the doctor will take tiny samples of the gut lining (biopsies). A specialized test called immunostaining can be used to see if the ALPI protein is actually present on the surface of the gut cells ^[4]. In ALPI-related IBD, this staining is often markedly reduced ^[4][6].

What the Pathologist Sees

Under a microscope, ALPI-related IBD often looks like a severe case of “standard” Crohn’s or ulcerative colitis. This is called an IBD-like pattern ^[7]. Common findings include:

• Chronic Active Colitis: Long-term inflammation that is currently “active” and aggressive ^[4].
• Architectural Distortion: The tiny “crypts” or glands in the gut lining look misshapen because the inflammation has been going on for so long ^[8].
• Endoscopy-Histology Mismatch: Sometimes, the gut lining looks relatively healthy to the doctor’s eye during the procedure, but the pathologist (the doctor looking at the tissue under a microscope) sees significant damage ^[9]. This can also happen in ordinary IBD through sampling differences.

Diagnostic Checklist

When you review your child’s medical reports, ensure the following pieces of the puzzle are evaluated to confirm a definitive ALPI diagnosis:

Practically, ask your clinic for a physical copy of the genetic testing report so you have the exact variant transcript details available if you transition to adult care or see a new specialist.